Top Line: Bausch + Lomb Corporation announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union. The company received a CE Mark late last year. 
Close Up: “Surgeons around the world have long known the benefits of the enVista platform,” said Luc Bonnefoy, president, surgical, Bausch + Lomb. “In the U.S., where enVista Aspire is currently available, surgeons and their patients appreciate the features of these monofocal lenses that are designed for a broader depth of focus, and we look forward to offering that feature in Europe as part of our comprehensive IOL portfolio.”
Unlike conventional spherical monofocal IOLs and lower-order aspheric IOLs, the enVista Aspire monofocal optics allow for a range of vision beyond one focal point. Like enVista MX60E, enVista Aspire offers a glistening-free optic material and controlled, efficient unfolding through Bausch + Lomb’s proprietary StableFlex Technology, which aids optic recovery.
Vital Stats: For patients with astigmatism, enVista Aspire Toric IOLs provide an option for treatment of their astigmatism during cataract surgery. Featuring a +0.90 cylinder design, the enVista toric IOL platform can treat less than one diopter of astigmatism at the corneal plane. The AccuSet haptic design enables rotational stability, an important attribute for toric lenses.
https://www.bausch.com/